FIGURE 1.

Activation of the sympathetic nervous system causes increased levels of catecholamines, which promote tumor cell activation and immune cell deactivation. Under adrenergic blockade using β‐blockers, immune cells can resist deactivation, invade tumor sites, and kill cancer cells. Furthermore, we see decreased tumorigenesis, less disease progression, increased response to immunotherapy, and improved overall survival